BioCentury | Sep 26, 2011
Company News

Orion Genomics, Qiagen deal

...methylation biomarkers in individual genes using the MethylScreen real-time quantitative PCR. Details were not disclosed. Orion Genomics LLC...
BioCentury | Aug 16, 2010
Strategy

Technology-agnostic diagnostics

...site and from patient to patient," she said. Novartis' MDx unit's first collaboration was with Orion Genomics LLC...
...products in its respective fields. Companies and Institutions Mentioned Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Orion Genomics LLC...
BioCentury | Oct 19, 2009
Company News

Orion Genomics, Novartis deal

...biomarkers in patient samples based on methylation patterns in DNA. Further terms were not disclosed. Orion Genomics LLC...
BioCentury | Jun 16, 2008
Company News

Orion Genomics, Johns Hopkins University deal

...university’s IP is focused on the imprinting abnormalities in IGF-2. Financial terms were not disclosed. Orion Genomics LLC...
BioCentury | Dec 24, 2007
Clinical News

Breast cancer biomarkers diagnostic data

...and specificity for a DNA-based (genetic or pigenetic) biomarker of breast cancer reported to date." Orion Genomics LLC...
BioCentury | Jan 30, 2006
Company News

Orion Genomics, University of Glasgow deal

...The collaborators plan to develop early stage screening tests for lung, breast and ovarian cancers. Orion Genomics LLC...
BioCentury | Jul 25, 2005
Company News

Orion Genomics management update

Orion Genomics LLC , St. Louis, Mo. Business: Cancer, Diagnostic, Pharmacogenetics Hired: Jorge Leon, as acting CSO, VP of business development and a director, while remaining president of Leomics Associates WIR Staff cancer Diagnostic...
BioCentury | Jun 13, 2005
Company News

Orion Genomics, The Johns Hopkins University deal

...normal and cancerous colon tissue, for use in developing early detection diagnostics for colon cancer. Orion Genomics LLC...
BioCentury | Jun 6, 2005
Emerging Company Profile

Corporate Profile

Orion Genomics LLC St. Louis, Mo. Technology: Epigenetics Disease focus: Cancer diagnostics Clinical status: NA Founded: 1998 by Richard Wilson, Robert Martienssen, Richard McCombie, and John McPherson University collaborators: Johns Hopkins University, Washington University School...
BioCentury | Jun 6, 2005
Emerging Company Profile

Orion: Dense diagnostics

...research has begun to yield evidence suggesting that aberrant DNA methylation is associated with disease. Orion Genomics LLC...
Items per page:
1 - 10 of 18
BioCentury | Sep 26, 2011
Company News

Orion Genomics, Qiagen deal

...methylation biomarkers in individual genes using the MethylScreen real-time quantitative PCR. Details were not disclosed. Orion Genomics LLC...
BioCentury | Aug 16, 2010
Strategy

Technology-agnostic diagnostics

...site and from patient to patient," she said. Novartis' MDx unit's first collaboration was with Orion Genomics LLC...
...products in its respective fields. Companies and Institutions Mentioned Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Orion Genomics LLC...
BioCentury | Oct 19, 2009
Company News

Orion Genomics, Novartis deal

...biomarkers in patient samples based on methylation patterns in DNA. Further terms were not disclosed. Orion Genomics LLC...
BioCentury | Jun 16, 2008
Company News

Orion Genomics, Johns Hopkins University deal

...university’s IP is focused on the imprinting abnormalities in IGF-2. Financial terms were not disclosed. Orion Genomics LLC...
BioCentury | Dec 24, 2007
Clinical News

Breast cancer biomarkers diagnostic data

...and specificity for a DNA-based (genetic or pigenetic) biomarker of breast cancer reported to date." Orion Genomics LLC...
BioCentury | Jan 30, 2006
Company News

Orion Genomics, University of Glasgow deal

...The collaborators plan to develop early stage screening tests for lung, breast and ovarian cancers. Orion Genomics LLC...
BioCentury | Jul 25, 2005
Company News

Orion Genomics management update

Orion Genomics LLC , St. Louis, Mo. Business: Cancer, Diagnostic, Pharmacogenetics Hired: Jorge Leon, as acting CSO, VP of business development and a director, while remaining president of Leomics Associates WIR Staff cancer Diagnostic...
BioCentury | Jun 13, 2005
Company News

Orion Genomics, The Johns Hopkins University deal

...normal and cancerous colon tissue, for use in developing early detection diagnostics for colon cancer. Orion Genomics LLC...
BioCentury | Jun 6, 2005
Emerging Company Profile

Corporate Profile

Orion Genomics LLC St. Louis, Mo. Technology: Epigenetics Disease focus: Cancer diagnostics Clinical status: NA Founded: 1998 by Richard Wilson, Robert Martienssen, Richard McCombie, and John McPherson University collaborators: Johns Hopkins University, Washington University School...
BioCentury | Jun 6, 2005
Emerging Company Profile

Orion: Dense diagnostics

...research has begun to yield evidence suggesting that aberrant DNA methylation is associated with disease. Orion Genomics LLC...
Items per page:
1 - 10 of 18